Acuta Capital Partners’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
2024
Q4
$3.68M Sell
2024
Q3
$15.5M Buy
2024
Q2
$8.34M Buy
2024
Q1
$7.16M Sell
2023
Q4
$7.37M Sell
2023
Q3
$6.17M Sell
2023
Q2
$6.1M Buy
2023
Q1
$4.52M Sell
2022
Q4
$6.93M Buy
2022
Q3
$2.04M Buy